Takeda Pharmaceutical Co. Ltd. - Diluted Average Shares

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Billions.

The item "Diluted-Average-Shares" stands at 6.38 Billion for the trailing twelve months (TTM) period ending 09/30/2025.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 1.58 Billion for the item "Diluted Average Shares" represents a decrease of -0.67 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 1.58 Billion for the item "Diluted Average Shares" represents a decrease of -2.02 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 6.38 Billion for the item "Diluted Average Shares" represents a decrease of -0.51 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.3547 percent compared to the value the year prior.
The 1 year change in percent is 0.3547.
The 3 year change in percent is 2.06.
The 5 year change in percent is 1.21.
The 10 year change in percent is 1.62.

The Serie's long term average value is 5.73 Billion. It's latest available value, on 09/30/2025, is 11.29 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2017, to it's latest available value, on 09/30/2025, is +103.41%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -0.522%.